US Physical Therapy Inc. (USPH) 2025 Annual Report – What Investors Need to Know

US Physical Therapy Inc. (NYSE: USPH) has released its Annual Report on Form 10-K for the fiscal year ended December 31, 2025. This document provides a comprehensive overview of the company’s operations, financial condition, growth strategies, risk factors, and other matters of potential interest to shareholders and investors.

Key Highlights from the 2025 Annual Report

• Business Overview:
  • USPH operates outpatient physical and occupational therapy clinics and provides industrial injury prevention (IIP) services. The company continues to expand its national footprint through acquisitions and organic growth.
  • As of February 23, 2026, USPH had 15,171,562 shares of common stock outstanding.
• Acquisitions and Growth:
  • USPH completed several significant acquisitions in 2024 and 2025, further strengthening its clinic network and industrial injury prevention business. Notable transactions include:
  • April 2025 Acquisition: 40% interest in a home-care business (details undisclosed).
  • February 2025 Acquisition: 65% interest in three clinics.
  • November 2024 Acquisition: 70% interest in eight clinics.
  • April 2024 Acquisition: 100% of an IIP business through Briotix Health Limited Partnership.
  • March 2024 Acquisition: 50% interest in nine clinics.
  • October 2023 Acquisition: 100% of an IIP business and 55% equity in an ergonomics software business.
• Clinic Activity:
  • USPH continues to expand, with quarterly additions and closures of clinics:
    • Q1 2025: 14 additions, 7 closures/sales
    • Q2 2025: 6 additions, 3 closures/sales
    • Q3 2025: 16 additions, 12 closures/sales
  • As of late 2025, the company operates over 700 clinics.
• Financial and Shareholder Information:
  • Market capitalization (public float) as of June 30, 2025: \$736.6 million based on NYSE closing price.
  • USPH is classified as a Large Accelerated Filer.
  • It is not an emerging growth company, and has filed all required reports and interactive data files with the SEC.
  • The company’s auditor has attested to the effectiveness of internal controls over financial reporting.
  • No restatements or material errors were reported in the financial statements.
  • USPH is not a shell company.

Material Information and Potential Share Price Impact

• Acquisition-Driven Growth:
  • The company’s aggressive acquisition strategy in both the clinic and IIP segments could drive future revenue and earnings growth. Multiple acquisitions in the past two years point to an ongoing consolidation strategy, which may be viewed favorably by investors seeking expansion and market share gains.
  • The acquisition of a 100% interest in an IIP business (Briotix Health LP) and a significant stake in an ergonomics software provider could position USPH for further growth in the industrial services arena, diversifying revenue streams beyond traditional therapy clinics.
• Clinic Network Optimization:
  • USPH continues to optimize its clinic portfolio, opening new locations while closing or selling underperforming ones. This dynamic management of its asset base could support margin improvement and operational efficiency.
• Risk Factors and Uncertainties:
  • USPH highlights numerous risks that could materially affect results, including:
    • Regulatory and reimbursement changes at federal and state levels.
    • Public health crises and government mandates impacting staffing, operations, and costs.
    • Debt levels and contingent consideration from acquisitions affecting financial flexibility.
    • Intense competition for qualified physical therapists, which could drive up costs or limit growth.
    • Potential for goodwill or intangible asset write-offs if clinic performance deteriorates.
    • Cybersecurity threats, integration of acquired businesses, and insurance coverage adequacy.
  • Shareholders should note the company’s forward-looking statements are subject to a wide range of uncertainties—actual results may differ materially from projections.
• Other Shareholder-Relevant Disclosures:
  • No financial statement restatements or incentive compensation clawbacks in the period.
  • Internal controls over financial reporting have been attested to by the company’s auditor, providing additional confidence in reported financials.

Conclusion

US Physical Therapy Inc. remains a consolidator in the outpatient therapy and industrial injury prevention markets, with recent acquisitions and portfolio optimization efforts likely to impact future financial performance. While the company faces sector-specific risks—reimbursement, regulatory, staffing, and integration challenges—it has maintained compliance, transparency, and strong governance practices. Investors should remain alert to ongoing acquisition activity, regulatory developments, and operational trends that could affect share value.

Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors should review the full 10-K report and consult with their financial advisor before making investment decisions. Forward-looking statements are subject to risks and uncertainties. Actual results may differ materially from those projected or implied.

View U S PHYSICAL THERAPY INC /NV Historical chart here